Open AccessPrimary cutaneous CD4‐positive small/medium T‐cell lymphoproliferative disorder: The first‐reported Latin‐American case with response to doxycycline
Author(s) -
Escanilla Claudio,
Guavita Falla Piedad Marcela,
Cevallos Carolina,
Ávalos Jobet Nicolás,
Bobadilla Bruneau Francisco
Publication year - 2019
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.2454
Subject(s) - medicine , doxycycline , lymphoproliferative disorders , dermatology , immunology , lymphoma , antibiotics , microbiology and biotechnology , biology
Primary cutaneous CD4+ small/medium T‐cell lymphoproliferative disorder is a provisional entity according to the last WHO‐EORTC classification. The treatment of choice has not yet been defined. Local therapies have been used with variable response. Doxycycline as a main treatment option is a potential low‐cost and effective alternative for this disorder.